{
  "type": "hyp",
  "text": "We screened 200 RTK target-based compounds and identified one (TKI-31) that potently inhibited VEGFR-2 kinase activity (IC50 =0.596 microM).\n",
  "self": {
    "NER": {
      "answers": [
        "200",
        "IC50",
        "microM"
      ],
      "QG_hash=ThomasNLG/t5-qg_squad1-en": {
        "questions": [
          "How many RTK target-based compounds were tested?",
          "What was the IC50 value of the target-based compounds?",
          "What was the IC50 of the target-based compounds?"
        ]
      }
    },
    "NOUN": {
      "answers": [
        "We",
        "200 RTK target-based compounds",
        "one (TKI-31) that potently inhibited VEGFR-2 kinase activity",
        "IC50",
        "0.596 microM"
      ],
      "QG_hash=ThomasNLG/t5-qg_squad1-en": {
        "questions": [
          "What was the IC50 of the target-based compounds?",
          "How many compounds were tested?",
          "What was the IC50 of the 200 RTK target-based compounds?",
          "What was the IC50 value of the target-based compounds?",
          "What was the IC50 of the target-based compounds?"
        ]
      }
    }
  },
  "asked": {
    "How many RTK target-based compounds were tested?": {
      "QA_hash=ThomasNLG/t5-qa_squad2neg-en": {
        "answer": "200",
        "answerability": 0.997739315032959,
        "ground_truth": {
          "200": {
            "bertscore": 1.0000001192092896,
            "f1": 1.0
          }
        }
      }
    },
    "What was the IC50 of the target-based compounds?": {
      "QA_hash=ThomasNLG/t5-qa_squad2neg-en": {
        "answer": "=0.596 microM",
        "answerability": 0.9694132208824158,
        "ground_truth": {
          "microM": {
            "bertscore": 0.7184022665023804,
            "f1": 0.6666666666666666
          },
          "We": {
            "bertscore": 0.5623739361763,
            "f1": 0
          },
          "IC50=0.596 microM": {
            "bertscore": 0.909727156162262,
            "f1": 0.5
          }
        }
      }
    },
    "How many compounds were tested?": {
      "QA_hash=ThomasNLG/t5-qa_squad2neg-en": {
        "answer": "200",
        "answerability": 0.9911727905273438,
        "ground_truth": {
          "200 RTK target-based compounds": {
            "bertscore": 0.6902872323989868,
            "f1": 0.4
          }
        }
      }
    },
    "What was the IC50 of the 200 RTK target-based compounds?": {
      "QA_hash=ThomasNLG/t5-qa_squad2neg-en": {
        "answer": "=0.596 microM",
        "answerability": 0.9633111953735352,
        "ground_truth": {
          "one (TKI-31) that potently inhibited VEGFR-2 kinase activity": {
            "bertscore": 0.5735073685646057,
            "f1": 0
          }
        }
      }
    }
  }
}